Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. View sample

Alzheimer's drugs slow progression of disease

Alzheimer's still has no cure, but two different types of drugs have been found to slow the progression of the disease.

By Mayo Clinic staff

Medication can improve the quality of life for people with Alzheimer's and their caregivers. It may even delay placement in a nursing home.

Unfortunately, Alzheimer's medications don't work for everyone. Some of the most commonly used drugs work in less than half the people tested. For those who are helped, the drugs' effects often are modest and temporary. Scientists continue to search for more effective drugs that might someday prevent Alzheimer's.

Two main types of drugs are currently approved by the Food and Drug Administration (FDA) for use in Alzheimer's. One variety seems to work best in the earlier stages of the disease, while the other is typically reserved for treatment of the later stages.

Cholinesterase inhibitors

Alzheimer's disease changes the brain in many ways. One of the changes results in a decrease in the levels of acetylcholine, a chemical messenger that's believed to be important for alertness, memory, thought and judgment. Cholinesterase inhibitors are a type of drug that improves the effectiveness of acetylcholine either by increasing the amount of it in the brain or by enhancing nerve cells' response to it.

Cholinesterase inhibitors work best in the early to middle stages of Alzheimer's, although at least one study has reported improvements in cognition and behavior in people who have moderate to severe Alzheimer's.

In clinical studies, on average, all cholinesterase inhibitors work equally well. But in individuals, one cholinesterase inhibitor may work better or produce fewer side effects than does another. Side effects can include nausea, vomiting and diarrhea.

Types of cholinesterase inhibitors

The most commonly prescribed cholinesterase inhibitors are donepezil (Aricept), galantamine (Razadyne) and rivastigmine (Exelon).

Donepezil (Aricept)
Perhaps the most prescribed cholinesterase inhibitor, donepezil was the first to offer convenient once-a-day dosing and is the least likely to produce serious side effects. This drug also appears to temporarily postpone the development of Alzheimer's in people with mild cognitive impairment (MCI), a memory-related condition that may precede Alzheimer's.

Galantamine (Razadyne)
Originally marketed as Reminyl, galantamine is taken twice a day with food, which can help reduce gastrointestinal side effects. It is also available in an extended release form designed to be taken once a day. Studies involving more than 2,000 people with MCI showed a significantly higher rate of death in those who took galantamine, compared with those receiving placebo. Half the deaths in the galantamine group were associated with heart attacks and strokes.

Rivastigmine (Exelon)
Rivastigmine may cause more severe gastrointestinal problems than other cholinesterase inhibitors do. Doctors typically prescribe a low dose of the drug initially and slowly increase the dosage as the body becomes accustomed to it. Taking the medication with food also may help. Rivastigmine is also now available in an adhesive patch, which may help reduce gastrointestinal side effects.

Next page
(1 of 2)

AZ00015

July 27, 2007

© 1998-2009 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Reliable tools for healthier lives," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Text Size: smaller largerlarger